药物警戒
医学
不利影响
药理学
不良事件报告系统
药物不良反应
重症监护医学
内科学
药品
作者
Xintian Xu,Lingxiao Zhang,Shouxin Zhang,Wanjing Huang,Liling Xie,Mao Ouyang
标识
DOI:10.1080/14740338.2024.2416540
摘要
Background Thrombopoietin receptor agonists (TPO-RAs) are currently approved for the treatment of thrombocytopenia in different conditions. The relationship between TPO-RAs and thromboembolic events (TEEs) remains controversial.
科研通智能强力驱动
Strongly Powered by AbleSci AI